m
Recent Posts
Connect with:
Thursday / November 19.
Homeminews (Page 922)

Macular Disease Foundation Australia (MDFA) has brought forward the opening date for applications for its next round of research funding to Thursday, 8 October

Findings from a retrospective study of children in Australia suggest myopia among disadvantaged Australian schoolchildren aged six to15 has doubled compared with 40 years

Luxturna (voretigene neparvovec) has been approved for use in Australia by the Therapeutics Goods Administration (TGA). TGA approval for Luxturna is indicated for the treatment

The Australian Medical Association has proposed a suite of policy solutions for Government to implement to reverse the decline of private health insurance.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.